Collegeville, PA, United States of America

June J Kim

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Collegeville, PA (US) (2013)
  • Brookline, MA (US) (2013)
  • West Chester, PA (US) (2015 - 2016)

Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: June J Kim: Innovator in Central Nervous System Therapeutics

Introduction

June J Kim is a prominent inventor based in Collegeville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic agents for central nervous system disorders. With a total of 7 patents to her name, her work has the potential to impact the treatment of various neurological and psychiatric conditions.

Latest Patents

Among her latest innovations are two notable patents. The first is for "1,3 substituted azetidine PDE10 inhibitors." This invention focuses on substituted azetidine compounds that serve as therapeutic agents for treating central nervous system disorders associated with phosphodiesterase 10 (PDE10). The compounds are particularly relevant for conditions such as schizophrenia, psychosis, and Huntington's disease, which are linked to striatal hypofunction or basal ganglia dysfunction. The second patent is for "Triazolyl PDE10 inhibitors," which also targets PDE10-related disorders. Similar to her first patent, this invention involves substituted triazolyl compounds that can be used to treat neurological and psychiatric disorders.

Career Highlights

June J Kim is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research and development efforts. Her work at this leading pharmaceutical company allows her to collaborate with other experts in the field and contribute to innovative solutions for complex health issues.

Collaborations

Some of her notable coworkers include Michael R Wood and Harold G Selnick. Their collaboration fosters a dynamic environment for innovation and the development of new therapeutic strategies.

Conclusion

June J Kim is a trailblazer in the field of central nervous system therapeutics, with a strong portfolio of patents that reflect her dedication to improving mental health treatments. Her contributions are poised to make a lasting impact on the medical community and the lives of those affected by neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…